A double-blind placebo-controlled crossover study exploring the cognitive effects of Brain Edge; a supplement consisting of a blend of herbs and amino acids. 50 healthy adult subjects will be evaluated over 3 sessions. Evaluation of cognitive performance will be determined by computer-based software, surveys, and VR headset experiences.
Who can participate
Age range18 Years – 64 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Men, women and non-binary adults, ≥18 and \<60 years old
* Generally healthy
* Ability to understand and the willingness to follow the study procedures.
* Willing to maintain a consistent diet (including medications, vitamins and supplements) and lifestyle routine throughout the study.
* Willing to give written informed consent to participate in the study.
Exclusion Criteria:
* Pregnant or nursing.
* Minors below the age of majority.
* Taking any prescription stimulants or anxiolytics.
* Typical caffeine intake above 250 mg/day.
* Neurological conditions including epilepsy, color blindness, ADD / ADHD, Learning disabilities, or dementia.
* Change in prescription, non-prescription, nutritional supplements and/or medical foods within 7 days prior to Day 1 and for the duration of the study.
* Use of prescriptions medications and/or nonprescription medications for acute and semi-acute medical conditions 30 days prior to Day 1 and for the duration of the study.
* Use of an investigational drug or participation in an investigational study within 30 days prior to Day 1 and for the duration of the study.
* Routine use of high dose caffeine \>250mg products within 7 days prior to Day 1 and for the duration of the study.
* Subjects with a history of allergy or intolerance to any ingredient in study product. Specific details of each product will be included in the formal Study Informed Consent.
* Serious, unstable illnesses including hepatic, renal, gastroentero…
What they're measuring
1
Number of participants with supplementation-related adverse events (AEs) as assessed by Common Terminology Criteria for Adverse Events v4.0 (CTCAE v4.0).